Clinical trials: Severe Malaria
Severe Malaria
Severe Malaria in Remote Areas- Closing the Evidence Gap
The goal of this observational study is to assess whether the giving of rectal artesunate and a three day course of an Artemisinin based Combination Therapy (ACT) to children aged 6 months and ≤ 5 years with severe malaria when…
- Trial name
- SEMA ReACT (NCT06806956)
- Testing
- Treatment of severe malaria with either RAS + ACT or RAS + injectable artesunate + ACT will each achieve the clinically acceptable cure rate of 97% ± 5% in remote areas
- Where
- 2 sites in Democratic Republic of the Congo, Zambia
- Volunteers
- 2,016 people
- Sponsor
- Tropical Diseases Research Centre, Zambia
Malaria, Fever
Examination of ACT Implementation in a Vivax / Falciparum Co-endemic Area
In areas of which are co-endemic for vivax and falciparum malaria, treatments for the two diseases often differ and this may lead to mistreatment. This places an emphasis on diagnosis at the health service provision level.
- Trial name
- NCT00935688
- Testing
- Rapid diagnostic test
- Where
- 2 sites in Afghanistan
- Volunteers
- 4,200 people
- Sponsor
- London School of Hygiene and Tropical Medicine
Falciparum Malaria
Clinical Evaluation of Long-term Sequelae in Patients With Severe Plasmodium Falciparum Malaria
Malaria, endemic in 85 countries, remains a major concern. By 2022, there will be 249 million cases and 608,000 deaths, 94% of them in Africa.
- Trial name
- SMAEE (NCT06992297)
- Testing
- Questionnaire
- Where
- France
- Volunteers
- 56 people
- Sponsor
- Assistance Publique Hopitaux De Marseille
Cerebral Malaria
Randomized Trial of Erythropoietin During Cerebral Malaria
Malaria remains one of the most common life-threatening illnesses in the tropics with a dramatic toll of more than one million deaths each year.
- Trial name
- EPOMAL (NCT00697164)
- Testing
- Erythropoietin
- Where
- Mali
- Volunteers
- 120 people
- Sponsor
- Claude Bernard University
Anemia
RBC Transfusion in Severe Anemia With Lactic Acidosis
The hypothesis of this study is that prolonged-storage RBCs are not inferior to short-storage RBCs for the time required to clear elevated blood lactate levels in children with severe anemia.
- Trial name
- TOTAL (NCT01586923)
- Testing
- RBC transfusion
- Where
- Uganda
- Volunteers
- 290 people
- Sponsor
- Massachusetts General Hospital
Severe Malaria
Malaria Treatment With Injectable ArteSunate
The MATIAS study aims to demonstrate through limited scope implementation studies how injectable artesunate may be progressively rolled out nationwide in the Democratic Republic of the Congo as the preferred treatment for severe…
- Trial name
- MATIAS (NCT01828333)
- Testing
- No intervention
- Where
- 9 sites in Democratic Republic of the Congo
- Volunteers
- 350 people
- Sponsor
- Swiss Tropical & Public Health Institute
Travel-Related Illness, Malaria
Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria
The investigators hypothesize that sex, age, area of exposure and purpose of travel are associated with different travel-related infections. The investigators also hypothesize that certain infections will have long-term sequelae.
- Conditions
- Travel-Related Illness, Malaria, Dengue, Chikungunya
- Trial name
- ITIT (NCT04672577)
- Testing
- Observational study
- Where
- Switzerland
- Volunteers
- 10,000 people, healthy volunteers welcome
- Sponsor
- Patricia Schlagenhauf
Malaria
Preventing Mental Health Problems After Childhood Severe Malaria
This is a randomized trial in which caregivers of children suffering from malaria will be assigned to two treatment conditions to prevent mental health problems in the children.
- Trial name
- NCT03432039
- Testing
- Psychoeducation, Behavioral
- Where
- Uganda
- Volunteers
- 120 people
- Sponsor
- Makerere University
Malaria, Falciparum, Plasmodium Falciparum
Clinical Practices for Treating Severe Malaria Caused by P. Falciparum
This study looks at how doctors in three hospitals in France treat patients with a serious form of malaria caused by Plasmodium falciparum. It focuses on cases where the level of malaria parasites in the blood is 4% or higher.
- Conditions
- Malaria, Falciparum, Plasmodium Falciparum, Antimalarials, Artemisinins
- Trial name
- NCT07027722
- Where
- France
- Volunteers
- 77 people
- Sponsor
- Centre Hospitalier de Saint-Denis
Malaria, Anemia
RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian Infants
The purpose of this trial is to evaluate the efficacy of weekly iron supplementation and the efficacy of malaria chemoprophylaxis from 2 to 12 months of age in infants living in an area of intense and perennial malaria…
- Trial name
- NCT00497471
- Testing
- Deltaprim (3.125 mg pyrimethamine plus 25 mg dapsone), iron (2 mg/kg/daily)
- Where
- Tanzania
- Volunteers
- 832 people, healthy volunteers welcome
- Sponsor
- Hospital Clinic of Barcelona
Severe Falciparum Malaria
Safety and Preliminary Efficacy of L-arginine in Severe Falciparum Malaria
Background: Mortality from severe malaria remains ~15% despite the use of the most rapidly parasiticidal antimalarial therapy, artesunate. Adjunctive treatments may improve outcome.
- Trial name
- ARGISM (NCT00616304)
- Testing
- L-arginine hydrochloride, Normal saline
- Where
- Indonesia
- Volunteers
- 8 people
- Sponsor
- Menzies School of Health Research
Malaria
Efficacy of Only IV Artesunate Versus IV Artesunate Plus IV Quinine in the Treatment of Severe Malaria in Children: A Comparative Study
The WHO recommends artesunate as the drug of choice for the treatment of severe malaria. However, the efficacy of this single drug as compared to the combined drug regimen remained questionable, and the clinical response was…
- Trial name
- NCT06472258
- Testing
- IV Artesunate, IV Quinine Hydrochloride
- Where
- Pakistan
- Volunteers
- 104 people
- Sponsor
- RESnTEC, Institute of Research